Meeting the Challenge of Psoriatic Disease: Optimal Care and Cost Management Strategies for Managed Care
Jointly provided by
Impact Education, LLC     		This activity is supported by independent educational grants from Celgene Corporation and Novartis Pharmaceuticals Corporation.

You Are Invited to a LIVE Free CME/CNE/CPE Webcast:
Meeting the Challenge of Psoriatic Disease: Optimal Care and Cost Management Strategies for Managed Care Live Webcast

Live Webcast Dates

DAY DATE TIME
Wednesday September 5, 2018 12:30 PM - 2:00 PM ET
Thursday September 27, 2018 1:00 PM - 2:30 PM ET
Tuesday October 9, 2018 1:00 PM - 2:30 PM ET
Tuesday October 30, 2018 12:30 PM - 2:00 PM ET


Click here to download the slides from this webcast series.

CUTTING EDGE TOPICS
  • Assessment of current and emerging therapies
  • Alignment of managed care treatment algorithms with recent clinical data
  • Application of care pathways as a cost management tool in psoriatic disease
  • Evolving specialty pharmacy and disease management services to improve outcomes
EXPERT FACULTY
Jeffrey D. Dunn, PharmD, MBA
Vice President
Clinical Strategy and Programs and Industry Relations
MagellanRx Management
Paul Yamauchi, MD, PhD
Clinical Assistant Professor of Dermatology
David Geffen School of Medicine at UCLA
Adjunct Associate Professor
John Wayne Cancer Institute
Robin Dore, MD
Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
WHO SHOULD ATTEND?
  • Managed care pharmacy directors, clinical pharmacists, quality directors, medical directors
  • Pharmacy directors, specialty pharmacists, quality directors, care managers, registered nurses, and other managed care and payer organization professionals
PROGRAM OVERVIEW

Psoriasis is one of the most common autoimmune diseases to develop in genetically susceptible individuals with an estimated 7.5 million Americans afflicted by psoriasis; and psoriatic arthritis is considered to be one of the most disabling types of arthritis affecting as many as 2.3 million Americans. As novel agents become available, treatment decision making is becoming more complex and managed care professionals need to appropriately and effectively design benefits that optimize both cost-efficiency and patient outcomes. The expert faculty panel will present the latest clinical data to recommend appropriate therapies, utilize care pathways, design appropriate medical and pharmacy benefits, and implement health care quality measures.

EDUCATIONAL OBJECTIVES

After completing the activity, participants should be better able to:
  • Assess current and emerging therapies for the treatment of psoriasis and psoriatic arthritis and cite their clinical trial data.
  • Examine alignment of managed care psoriatic disease treatment algorithms with recent clinical trial data.
  • Describe care pathways and their application as a cost management tool in psoriatic disease.
  • Employ specialty pharmacy and disease management services for psoriatic disease patients.
AGENDA
Opening Comments/Overview
Jeffrey D. Dunn, PharmD, MBA
Psoriasis Clinical Update: Assessing the Latest Trial Data and Treatment Algorithms
Paul Yamauchi, MD, PhD
Psoriatic Arthritis Clinical Update: Assessing the Latest Trial Data and Treatment Algorithms
Robin Dore, MD
Care Pathways in Psoriatic Disease: Recommendations for Managed Care
Jeffrey D. Dunn, PharmD, MBA
Improving Patient Outcomes with Specialty Pharmacy Services and Disease Management Strategies
Jeffrey D. Dunn, PharmD, MBA
Audience Question and Answer Session

Key Takeaways and Closing Comments
ACCREDITATION INFORMATION
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008162-9999-18-081-L01-P
Type of Activity: Application

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up.

Fee Information
There is no fee for this educational activity.

Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.

If you have any questions, please call (215) 619-8812 or email info@impactedu.net.